Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ

Sponsor
Gazi University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05970939
Collaborator
(none)
60
1
1
58.9

Study Details

Study Description

Brief Summary

Neurological diseases are central nervous system diseases that cause an increase in the level of disability and limitations in daily life. Multiple Sclerosis (MS), stroke, and Parkinson's Disease (PD) are among the most common apparent neurological diseases, and epidemiological studies show that their prevalence has increased over time worldwide. Although MS, stroke, and PD have different causes and neurological aspects, they generally cause motor, sensory, and/or cognitive impairments, leading to restriction of the individual's activities and participation. Today, physiotherapy and rehabilitation approaches together with optimal medical and surgical treatment are the cornerstones of treatment for these diseases. Recently, it has been stated that various telerehabilitation interventions in the field of physiotherapy and rehabilitation may be an additional option to the rehabilitation approaches applied in the clinic. On the other hand, It is important to evaluate the level of usability in expanding the usability of telerehabilitation services and determining the best telerehabilitation service. For this reason, there is a need for questionnaires investigating the satisfaction level of physiotherapy and rehabilitation applied through telerehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Other: Development of the Telerehabilitation Usability Questionnaire

Detailed Description

Questionnaire items will be created in two stages. First, 5 experts will independently review the literature on "telerehabilitation" and "usability". In addition, these experts will be asked to create a pool of questions based on their experiences in telerehabilitation and by taking the opinions of patients receiving telerehabilitation about usability. Then, 5 experts will come together and obtain a single question pool containing the questions they deem important in their question pool. The second step will involve scaling the elements. In this study, scale items will be scored on a five-point Likert scale, ranging from 1, strongly disagree to 5, strongly agree. Then, it will be applied to a pilot group of 10 people and it will be evaluated whether the items prepared by the experts are understood by the patients. In line with the expert opinion and the result of the pilot study, the final version of the scale will be decided and applied to MS, PD, and stroke patients who make up the study group. Finally, the validity and reliability of the questionnaire will be calculated.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ in Neurological Diseases
Anticipated Study Start Date :
Jul 28, 2023
Anticipated Primary Completion Date :
Aug 28, 2023
Anticipated Study Completion Date :
Aug 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Telerehabilitation Usability

Telerehabilitation Usability Group

Other: Development of the Telerehabilitation Usability Questionnaire
This study will be examined the development, validity, and reliability of the Telerehabilitation Usability Questionnaire in patients with MS.

Outcome Measures

Primary Outcome Measures

  1. Telerehabilitation Usability Questionnaire in patients with Neurological disease [Baseline]

    Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale

  2. Telerehabilitation Usability Questionnaire in patients with Neurological disease-Second [he second assessment will be conducted after the one week]

    Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Voluntarily participate in research to accept

  • Mini-Mental Test score more than or equal 24

  • Previously receiving physical therapy through telerehabilitation

Exclusion Criteria:
  • Any visual, hearing, and perception problems that may affect the answering the questionnaire items

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gazi University Ankara Turkey

Sponsors and Collaborators

  • Gazi University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Kader Eldemir, principal investigator, T.C. ORDU ÜNİVERSİTESİ
ClinicalTrials.gov Identifier:
NCT05970939
Other Study ID Numbers:
  • ND-Development-TrUQ
First Posted:
Aug 2, 2023
Last Update Posted:
Aug 3, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kader Eldemir, principal investigator, T.C. ORDU ÜNİVERSİTESİ
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2023